Business Description
Onward Medical NV
ISIN : NL0015000HT4
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.76 | |||||
Equity-to-Asset | 0.41 | |||||
Debt-to-Equity | 0.94 | |||||
Debt-to-EBITDA | -0.5 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 24.3 | |||||
3-Year EPS without NRI Growth Rate | 29.3 | |||||
3-Year FCF Growth Rate | 21.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.55 | |||||
9-Day RSI | 45.83 | |||||
14-Day RSI | 46.6 | |||||
6-1 Month Momentum % | 48.98 | |||||
12-1 Month Momentum % | 23.47 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.7 | |||||
Quick Ratio | 4.7 | |||||
Cash Ratio | 4.46 | |||||
Days Payable | 717.06 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -72.3 | |||||
Shareholder Yield % | -1.3 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -103.54 | |||||
ROA % | -60.55 | |||||
ROIC % | -257.33 | |||||
ROC (Joel Greenblatt) % | -1647.58 | |||||
ROCE % | -66.4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 8.55 | |||||
Price-to-Tangible-Book | 18.31 | |||||
EV-to-EBIT | -4.46 | |||||
EV-to-EBITDA | -4.55 | |||||
EV-to-FCF | -4.76 | |||||
Price-to-Net-Current-Asset-Value | 26.44 | |||||
Price-to-Net-Cash | 36.62 | |||||
Earnings Yield (Greenblatt) % | -22.42 | |||||
FCF Yield % | -19.51 |